EQUITY (Details Narrative) - USD ($) |
1 Months Ended | 6 Months Ended | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
May 06, 2026 |
Nov. 12, 2025 |
Jul. 02, 2025 |
May 09, 2025 |
Jun. 30, 2026 |
Jan. 30, 2026 |
Feb. 18, 2025 |
Jun. 30, 2026 |
Dec. 31, 2025 |
Oct. 27, 2025 |
Jun. 30, 2025 |
|
| Collaborative Arrangement and Arrangement Other than Collaborative [Line Items] | |||||||||||
| Deferred offering costs | $ 268,254 | $ 268,254 | $ 150,000 | ||||||||
| Stock-based compensation expense | $ 61,333 | ||||||||||
| Restricted Stock Units (RSUs) [Member] | |||||||||||
| Collaborative Arrangement and Arrangement Other than Collaborative [Line Items] | |||||||||||
| Rsu granted | 585,288 | ||||||||||
| Share price of rsu garnt | $ 6.81 | ||||||||||
| Aggregate grant date fair value | $ 3,990,000 | ||||||||||
| Unrecognized compensation cost | $ 3,700,000 | $ 3,700,000 | |||||||||
| Weighted-average period | 2 years 5 months 4 days | ||||||||||
| 2025 Equity Incentive Plan [Member] | |||||||||||
| Collaborative Arrangement and Arrangement Other than Collaborative [Line Items] | |||||||||||
| Shares available for grant | 1,394,230 | ||||||||||
| July 2025 Warrant [Member] | |||||||||||
| Collaborative Arrangement and Arrangement Other than Collaborative [Line Items] | |||||||||||
| Warrants to purchase | 404,002 | ||||||||||
| Exercise price | $ 0.01 | ||||||||||
| Fair value of warrant | $ 2.67 | ||||||||||
| Expected term | 4 months 26 days | ||||||||||
| Risk-free interest rate | 4.33% | ||||||||||
| Expected volatility | 90.00% | ||||||||||
| Dividend yield | 0.00% | ||||||||||
| Fair value of warrant | $ 1,074,715 | ||||||||||
| Lazar [Member] | |||||||||||
| Collaborative Arrangement and Arrangement Other than Collaborative [Line Items] | |||||||||||
| Number of warrant cashless exercised | 402,347 | ||||||||||
| Two Director [Member] | |||||||||||
| Collaborative Arrangement and Arrangement Other than Collaborative [Line Items] | |||||||||||
| Share price | $ 0.01 | ||||||||||
| Number of shares issued for settlement of awards | 200,000 | ||||||||||
| Fair value of shares issued | 2,000 | ||||||||||
| Reduction to additional paid-in capital | $ 2,000 | ||||||||||
| Accumulated stock-based compensation expense | $ 2,000 | ||||||||||
| Securities Purchase Agreement [Member] | Cao Yu [Member] | |||||||||||
| Collaborative Arrangement and Arrangement Other than Collaborative [Line Items] | |||||||||||
| Number of common stock sold | 1,585,366 | ||||||||||
| Aggregate purchase price | $ 2,600,000 | ||||||||||
| Securities Purchase Agreement [Member] | Hu Bin [Member] | |||||||||||
| Collaborative Arrangement and Arrangement Other than Collaborative [Line Items] | |||||||||||
| Number of common stock sold | 853,659 | ||||||||||
| Aggregate purchase price | $ 1,400,000 | ||||||||||
| Securities Purchase Agreement [Member] | Purchasers [Member] | |||||||||||
| Collaborative Arrangement and Arrangement Other than Collaborative [Line Items] | |||||||||||
| Number of common stock sold | 394,476 | ||||||||||
| Aggregate purchase price | $ 1,999,993 | ||||||||||
| Share price | $ 5.07 | ||||||||||
| Common stock description | Common Stock and $1,996,048 was recorded as additional paid-in capital (“APIC”), net of $53,823 of legal fees related to the offering, which were charged to APIC. | ||||||||||
| Helena Purchase Agreement [Member] | |||||||||||
| Collaborative Arrangement and Arrangement Other than Collaborative [Line Items] | |||||||||||
| Commitment fee shares description | Company issued to Helena, as a commitment fee, shares of Common Stock (the “Commitment Fee Shares”), having an aggregate value of $150,000, of which (i) 71,572 shares of Common Stock were issued on May 14, 2025, and (ii) 71,572 shares of Common Stock were issued on August 11, 2025. The Commitment Fee Shares were fully earned as of the execution date of the Helena Purchase Agreement, and the issuance of the Commitment Fee Shares was not contingent upon any other event or condition. The number of the Commitment Fee Shares issued in each tranche was determined by dividing $75,000 by the lowest Volume Weighted Average Price (VWAP) of the Common Stock during the five trading days immediately preceding the agreement date. | ||||||||||
| Deferred offering costs | $ 150,000 | ||||||||||
| ATM Sales Agreement [Member] | |||||||||||
| Collaborative Arrangement and Arrangement Other than Collaborative [Line Items] | |||||||||||
| Sales agreement description | Company entered into a sales agreement (the “Sales Agreement”) with A.G.P./Alliance Global Partners (“A.G.P.”) under which the Company may offer and sell up to an estimated $6,272,809 of shares of Common Stock from time to time through an “at the market” offering program under which A.G.P. will act as sales agent. Pursuant to the Sales Agreement, the Company has agreed to pay A.G.P. a commission of 3.25% of the aggregate gross proceeds from any shares of Common Stock sold by A.G.P. The Company has no obligation to sell any shares under the Sales Agreement and may at any time suspend solicitation and offers under the Sales Agreement. | ||||||||||
| Series A Convertible Preferred Stock [Member] | |||||||||||
| Collaborative Arrangement and Arrangement Other than Collaborative [Line Items] | |||||||||||
| Preferred stock, shares issued | 2,305,357 | 2,305,357 | 2,305,357 | ||||||||
| Preferred stock, shares outstanding | 2,305,357 | 2,305,357 | 2,305,357 | ||||||||
| Series A Convertible Preferred Stock [Member] | Securities Purchase Agreement [Member] | |||||||||||
| Collaborative Arrangement and Arrangement Other than Collaborative [Line Items] | |||||||||||
| Securities purchase agreement description | Company entered into a Securities Purchase Agreement (the “February 18, 2025 SPA”) with Lazar, and Cao Yu, Hu Bin, and Youxin Consulting Limited (collectively, the “Purchasers”), which was subsequently amended on May 9, 2025. Pursuant to the February 18, 2025 SPA and its amendment, Lazar, a former director and officer of the Company, sold to the Purchasers (i) 2,219,447 shares of Series A Preferred Stock, (ii) a warrant to purchase up to 2,800,000 shares of Common Stock at an exercise price of $1.00 per share, subject to adjustment (the “Warrant”), and (iii) certain receivables owed by the Company to Lazar associated with the transaction (the “Lazar Receivables”). On April 10, 2025, Lazar transferred an additional 31,258 shares of Series A Preferred Stock to the Purchasers (together with the previously transferred shares and the Warrant, the “Securities”). The aggregate purchase price for the Securities and the Lazar Receivables was $500,000, of which $300,000 was directed by Lazar to be paid to the Company in exchange for a convertible note. The Purchasers also paid a $3.4 million earn-out payment to Lazar for his efforts related to the Company’s successful relisting on Nasdaq as of June 30, 2025. | ||||||||||
| Series A Preferred Stock [Member] | |||||||||||
| Collaborative Arrangement and Arrangement Other than Collaborative [Line Items] | |||||||||||
| Preferred stock, shares issued | 2,305,357 | 2,305,357 | 2,305,357 | ||||||||
| Preferred stock, shares outstanding | 2,305,357 | 2,305,357 | 2,305,357 | ||||||||
| Preferred stock, conversion basis | Each share of Series A Preferred Stock is convertible, at the option of the holder, into 1.4 shares of Common Stock, votes on an as-if-converted basis, and has full ratchet protection in any subsequent offerings. | ||||||||||